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 Abstract 
 
Fused-In-Sarcoma (FUS) is a candidate gene for neurological disorders including motor neurone 
disease and Parkinson’s disease in addition to various types of cancer.  Recently it has been reported 
that over expression of FUS causes motor neurone disease in mouse models hence mutations 
leading to changes in gene expression may contribute to the development of neurodegenerative 
disease.  Genome evolutionary conservation was used to predict important cis-acting DNA regulators 
of the FUS gene promoter that direct transcription.  The putative regulators identified were analysed 
in reporter gene assays in cells and in chick embryos.  Our analysis indicated in addition to regulatory 
domains 5’ of the transcriptional start site an important regulatory domain resides in intron 1 of the 
gene itself.  This intronic domain functioned both in cell lines and in vivo in the neural tube of the 
chick embryo including developing motor neurones. Our data suggests the interaction of multiple 
domains including intronic domains are involved in expression of FUS.  A better understanding of the 
regulation of expression of FUS may give insight into how its stimulus inducible expression may be 
associated with neurological disorders. 
  
 1.  Introduction 
 
FUS (fused in sarcoma) is an RNA binding protein, associated with the spliceosomal complex, which 
was identified as a candidate gene for genetic association with amylotrophic lateral sclerosis (ALS) 
susceptibility or survival [1-2].  The number of ALS cases attributed to mutations in the FUS gene is 
small; FUS mutations are present but rare in Sporadic ALS at around 1% [3-6] and found in only 3-5% 
of Familial ALS [1-2].  However recently, further mutations were identified located in the 3’UTR of 
the FUS gene in some individuals with ALS (1.2 %)[7].   It has been proposed that levels of FUS 
protein may be critical for cell phenotype and initiation or progression of specific neurological 
disorders including ALS [8-10].  For example wild type FUS when over expressed in a transgenic 
mouse model resulted in progressive degeneration of motor neurons in a dose-dependent manner 
[9].  Furthermore the 3’UTR mutations described above, were associated with increased levels of Fus 
protein and empirical observations of the limited number of cases identified, suggested that the 
level of protein over-abundance was mirrored by the severity of the disease.  In vitro, FUS 
knockdown leads to preferential inclusion of tau exons 3 and 10 which in turn leads to disruption of 
tau function.  Similarly tau exon 10 inclusion is also associated with frontotemporal dementia (FTD) 
and Parkinson’ disease.  Thus tau splicing is a potential target of FUS function in neurons [11].   
Taken together this suggests that mechanisms that control FUS expression, either the absolute levels 
of expression, the isoforms expressed or indeed post-transcriptional or translational control 
mechanisms may be critical for the involvement of this protein in neurological disorders. This would 
be consistent with a model where either mutation of the protein or differential regulation of the 
gene transcription or translation could lead to dysregulation of gene networks or pathway.   For 
example, both the mutant forms of FUS or excessive amounts of normal FUS protein lead to 
perturbed localization of FUS in the cytoplasm rather than in the nucleus of the cell [9,12-14].  
Mutant FUS is located in stress granules while wild type FUS forms globular and skein-like inclusions.  
In both cases the pathological accumulation of cytoplasmic FUS is thought to contribute directly to 
the death of the motor neurones. 
Other than the recent findings describing mutations in the 3’UTR, little is known about the 
mechanisms regulating FUS expression. Here, we define important regulatory domains spanning the 
predicted major transcriptional start site using in vitro reporter gene assays. These domains were 
predicted using comparative genomics, selecting evolutionary conserved regions (ECRs) and putative 
promoter for the in vitro analysis.  We next established an in vivo model to address their potential 
function in an appropriate anatomical location, specifically in motor neurones of the chick embryo 
[15].   
 
2.  Results 
2.1  An upstream (ECR) and intronic (INT) region are conserved during evolution 
Comparative genome analysis can highlight which regions of the genome have been conserved 
during evolution using genome browsers such as UCSC genome browser and the ECR browser [16-
17].  This analysis of course identifies the exons, but can also pinpoint regions in the non coding 
genome that may have a function.    When this analysis was applied to the FUS gene we observed 
that a high degree of conservation was observed both 5’ and 3’ of the predicted major 
transcriptional start site (MTSS), located at Chr16: 31,191,429 (Figure 1A).  In this analysis the 
shaded area indicated more than 70% conservation and the peak height corresponded to the 
percentage conservation over 100bp regions. The width of the peak corresponds to number of bases 
in the domains. This analysis identified, as might be predicted, a domain continuous with the MTSS, 
we termed the proximal promoter (PP).  This region included 137 bp upstream of the MTSS and the 
untranslated part of exon 1 (106bp).  A further upstream region   we termed evolutionary conserved 
region (ECR), was also conserved.  It was 311bp in length and located 29bp 5’ to PP; co-ordinates 
were Chr 16:31,190,954 – 31,191,264.  However we found  that a 5’ portion of the first intron 
continous with exon 1, a domain we termed INT (704bp) was the most highly conserved region 
amongst the species analysed and could therefore contain an important regulatory domain.  No 
other significant conserved homology was observed in a region encompassing 4kb on either side of 
the MTSS in the species analysed , other than the exons. These three domains  were amplified by 
PCR and cloned into reporter gene plasmids as shown in Figure 1B & C, to test their ability to support 
reporter gene expression. 
 
2.2 ECR and INT enhance expression with both FUS and SV40 promoters in vitro  
Regulatory domains often work better with their own proximal promoter [18], therefore the initial 
set of constructs analysed were contiguous with the predicted MTSS of FUS and tested in the 
neuroblastoma cell line, SK-N-AS in which we had confirmed expression of the endogenous FUS gene 
(data not shown).  PP (243bp) was a robust and strong promoter which drove expression of 
luciferase marker gene when tested in the promoter-less pGL3b vector (p<0.002) (Figure 2A).  
Constructs that contained either the ECR or INT domain in combination with PP, both gave small but 
significant increases in expression, consistent with an ability to act as regulatory domains (Figure 
2A).  Thus ECR and INT are proposed to be activators of transcription rather than repressors of 
expression in the SK-N-AS cell line. In these experiments the ECR and INT domains were maintained 
in the same order, relative to the MTSS, as found in the genome, specifically the INT domain was 
maintained after the MTSS, therefore it could still modulate via post transcriptional activity.  We 
then tested the ability of both the ECR and INT domains to act as transcriptional regulators by 
cloning them upstream of the heterologous SV40 promoter in the pGL3p reporter gene vector (Fig 
1B).  In this model both domains acted as positive regulators of expression with INT having 
significantly greater effect (Figure 2B).  
Regulatory domains can demonstrate cell/ tissue specific and stimulus-inducible parameters when 
tested in vitro and in vivo. To address this, we tested the pGL3p constructs in the hybrid 
neuroblastoma/motor neuron cell line NSC-34 cells (Figure 2C).  In this line we again generated 
evidence that these elements could act as positive regulators of expression furthermore the INT 
domain showed an increased level of activity to that observed in the SK-N-AS cell line whilst the level 
of activity of the ECR was the same. This analysis indicated that in the cell models tested, the INT 
domain had a major transcriptional regulatory activity.    
2.3 ECR and INT enhance expression in vivo in developing motor neurons  
To further investigate the function of these domains we extended our analysis to include a chick 
embryo in vivo model [15].  Electroporation of chick embryos is a rapid and inexpensive method of 
examining the in vivo behaviour of DNA regulatory domains in the appropriate tissues, in this case 
motor neurons. To establish the validity of analysing reporter gene expression in embryonic day 5 
(E5) embryos, endogenous chick FUS expression was analysed by RT-PCR and immunohistochemistry  
(Figure 3). By about E5 (HH25) the motor column is clearly apparent within the neural tube and 
markers of developing motor neurons are expressed [19].   FUS expression was detected in the 
neural tube at E5 (Fig 3C) and immunohistochemistry demonstrated  that at this stage of 
development FUS was expressed ubiquitously in cross sections of the trunk of the embryo (Fig 3A) 
and more specifically cell nuclei in all regions of the neural tube including the motor column were 
stained.  The region of the developing motor column was identified by Hox gene family member, 
HB9 staining (S1) [20].   
For in vivo analysis, the putative regulatory domains were cloned upstream of a hrGFP reporter gene 
(Figure 1C).  TdTomato fluorescent protein expressed under a constitutive β actin promoter was 
used as a marker to identify embryos which had undergone successful injection and electroporation 
of the neural tube.  Preliminary experiments were carried out to ensure there was no overflow of 
fluorescence between the green and red channels when visualising hrGFP and Tomato proteins (data 
not shown).   When the ECR PP construct was electroporated into the neural tube, hrGFP was 
detected along  the length of the neural tube corresponding to the area of successful 
electroporation as delineated by the tdTomato marker gene activity (Figure 4A), this demonstration 
corroborated  the finding that ECR PP had activity in SK-N-AS cells (Figure 2A).  Cross sections of the 
neural tube confirmed that hrGFP fluorescence was seen in all regions that had been successfully 
electroporated including the developing motor column (Figure 4 D, E).  To test whether ECR was 
acting as a regulatory domain, enhancing expression, the PP domain alone construct was 
electroporated.  It was found that PP alone was not a sufficiently strong promoter to drive 
detectable levels of hrGFP fluorescence in this model (Figure 4 G, H).  Since hrGFP fluorescence could 
not be detected in vivo driven by PP we confirmed that this plasmid was functional by transfection 
into SK-N-AS cells.  We were able to show the PP construct drove expression of hrGFP in transfected 
SK-N-AS (Figure S2).  These results demonstrated the ability of the ECR domain to enhance the 
activity of PP both in vivo and in vitro as well as enhancing the activity of the heterologous SV40 
promoter in pGL3p.   
INT was cloned upstream of PP and ECR PP (Figure 1C) to test whether this region could also act as a 
regulatory domain for transcription in vivo.  INT PP drove hrGFP expression in the neural tube, thus 
confirming the ability of this region to act as a positive regulator of transcription in the in vivo model 
as well as in cell lines (Figure 5).  As could be predicted, INT ECR PP also drove expression in the 
neural tube (Figure 5).  Taken together these results show that both the ECR upstream of the FUS 
promoter and the evolutionary conserved region in intron 1 act as positive regulators of FUS 
expression in both cell lines and in the chick neural tube including the region of the developing 
motor neurons.    
 
3.  Discussion 
 
The use of comparative genome analysis highlighted the potential for an important regulatory 
domain of FUS in the 1st intron of FUS. Conventional analysis would more likely have used a large 5’ 
promoter fragment reporter gene construct with subsequent deletions from the 5’ end of the 
fragment to define elements within the promoter. Transcriptional regulatory domains that can be as 
distant as 100kb+ from the gene they are predicted to regulate [18,21]. The comparative genome 
approach immediately identifies some of the important domains with no bias as to their location. 
The 704bp fragment of intron 1 and the 311bp fragment upstream of the PP both enhanced 
transcription when linked with either the SV40 promoter or the FUS PP. In tissue culture 
experiments with SK-N-AS it was possible that INT might have acted as a post transcription activator 
however in subsequent experiments where it was clone upstream of SV40 or PP in the phrGFP 
plasmid INT must have been acting on transcriptional activity.   It was also of interest that INT 
supported the greatest activity in the hybrid neuroblastoma/motor neuron cell line.  Surprisingly PP 
alone worked only in cultured cells but not in the chick embryo neural tube suggesting either the cell 
environment and cell phenotype play an important role in governing the response of regulatory 
sequences or there was a substantial difference in the sensitivity of the two systems.  Chick embryos 
have been used as a model for understanding the tissue-specific regulation of genes that are 
important during development [15] but so far this approach has not extended to genes primarily of 
interest due to roles in the adult and neurodegenerative diseases.  Our results suggest that chick 
embryos will be a useful addition to the reporter gene assays currently used provided the candidate 
gene of interest is expressed in the differentiating cells in the embryo.  Use of chick embryos 
synergises particularly well with the comparative genome approach where human regulatory 
sequences are identified based on their conservation with chick or even fish genomes.   
Unsurprisingly the human regulatory sequences clearly respond appropriately to the chick 
environment and previous work has shown that human sequences respond to a mouse environment 
even when the sequences are not conserved in mouse [22-23].  Most recently a primate specific 
retrotransposon of the SINE-VNTR-Alu (SVA) family, located upstream of the FUS gene has also been 
shown to drive expression in the chick embryo neural tube further demonstrating the versatility of 
this model [24].    
Polymorphisms or mutations leading to disregulation of gene expression may lie at the heart of 
understanding the causes of neurodegenerative diseases like ALS and frontotemporal lobar 
degeneration, rather than mutations within the coding region of proteins.  Identification of the DNA 
sequences that regulate FUS expression in motor neurons provides an important step in our 
understanding of the genetic features that promote these diseases.  Mutations within the cis-acting 
regulatory domains or 3’ UTR mutations of FUS may have a profound effect on its spatial and 
temporal expression levels and these in turn can lead to changes in the cellular location of FUS and 
the formation of globular and granular cytoplasmic inclusions and eventual loss of motor neurons 
[7,12-14]. In keeping with this proposal SNPs occur within PP and INT although none so far are have 
been identified within the upstream ECR.     Further analysis will be required to demonstrate 
whether these or other genetic changes modify the expression of the FUS protein.    
Here we have used a combination of models to demonstrate robustly the activity of the cis-acting 
elements identified in the 5’ region of the FUS gene.  Crucially INT, a 704bp conserved region within 
intron 1, increases expression of reporter genes in two cell lines, with two promoters (FUS and SV40) 
and in the neural tube in vivo making it a region of specific interest in view of recent results linking 
FUS over expression with motor neuron degeneration [9].  The approach used here will be applicable 
to the analysis of several genes whose over expression is implicated in the development and 
progression of ALS and other neurodegenerative diseases [25]. 
 
4.  Materials and Methods 
 
4.1  Comparative Genomics   
Evolutionary conserved regions (ECRs) potentially containing regulatory elements were identified 
by genomic comparison using the ECR Browser (http://ecrbrowser.dcode.org; [17]) and the UCSC 
Genome Browser (http://genome.ucsc.edu;  [16]). Human FUS was compared with chimpanzee, dog, 
rat and mouse using 70% identity and a length of 100bp as the parameters to identify conserved 
sequences.  A region 4kB upstream and downstream was analysed and coordinates of conserved 
regions were obtained from Hg19 build.   
 
4.2  Reporter Gene Construction for in vitro analysis 
Regions of interest identified above, were extended by 100-200 bp on either side to facilitate 
primer design. All regions were amplified by high fidelity PCR from pooled mixed gender human 
genomic DNA preparations (Promega, USA) using Pfu DNA polymerase (Promega, USA). Restriction 
enzyme sites were included at the 5’ end of primers to facilitate directional cloning (forward: NheI, 
reverse: BglII underlined below,) and the first two PCR-cycles were performed at annealing 
temperatures to match template-specific sequences exclusively. The following primers were 
designed:  INT-forward 5’-GGCTAGCCATGGCCTCAAACGGTAGGTAAGG-3’, INT-reverse 5’-
GAGATCTCGAAAGAAATTTAGGCGGGAAAAACTCTCGGGC-3’, PP-forward 5’-
GGCTAGCCATGATTCTAGTTAACTTGTTTCCCTTCTGCCTGCTCGGACCC-3’, PP-reverse 5’-
GAGATCTCGTCCGCGCACGCGCGCAC-3’,   ECR-forward 5’-
GGCTAGCCAGAGGGAGGGCCAGTGTGCTGCC-3’, ECR-reverse 5’- 
GAGATCTCGAGGAAGAACCCCTCTCTCCTCGGCAG-3’.  PCR products INT (704bp), PP (243bp), ECR 
(311bp), PP INT (948bp) and ECR PP (582bp) were cloned into firefly luciferase reporter gene 
expressing vectors pGL3p, containing a SV40 minimal promoter element, or pGL3b, containing no 
promoter (both Promega, USA). Correct cloning and sequence were verified by bi-directional 
sequencing using standardized primers.  
 
 4.3  Cell Culture and Cell Transfection 
Human neuroblastoma SK-N-AS cells (American Type Culture Collection Resource Centre stock 
number CRL-2137) were maintained in Dulbecco’s Modified Eagle’s high glucose medium (Sigma, 
D5672), 10% feotal bovine serum (ThermoScientific/Hyclone), 100 U/ml penicillin,100 μg/ml 
streptomycin, Sigma P0781), 1% Non-Essential Amino Acids (Sigma, M7145) and 200 mM L-
glutamine (Sigma, D7513), in 5% CO2 at 37°C.  Murine motor neuron-like neuroblastoma hybrid NSC-
34 cells were obtained from Professor Pamela Shaw, Department of Neuroscience, University of 
Sheffield and maintained in Dulbecco’s Modified Eagle’s high glucose medium (Sigma, D5672), 10% 
feotal bovine serum (ThermoScientific/Hyclone,) and 100 U/ml penicillin, 100 μg/ml, streptomycin 
(Sigma P0781), in 5% CO2 at 37°C [26]. SK-N-AS and NSC-34 cells were co-transfected with 1 ?g of 
test reporter gene construct and 20 ng of internal control DNA (pMLuc2; renilla luciferase reporter 
gene; Merck Biosciences, Nottingham, UK) using TurboFect Transfection Reagent 
(ThermoScientific/Fermentas, R0531) according to manufacturer’s protocol in the 24-well plate 
format. Each transfection was performed in six wells and experiments were repeated at least three 
times. Similarly SK-N-AS cells were transfected with 1 ?g/well of GFP reporter plasmids. Transfectant 
was removed after 4 hours of incubation and exchanged with fresh medium and analysed using a 
Leica inverted microscope 48 hours later (n=4). 
 
4.4  Luciferase-Assays.  
Luciferase activity was measured using dual luciferase assay kits (Promega). Briefly, cell cultures 
were lysed and the proteins stabilized using the passive lysis buffer as per the manufacturer’s 
instructions. Luciferase activity was measured using a Glomax 96-microplate luminometer 
(Promega). Background from untransfected cells was subtracted from all luciferase and renilla 
values. Luciferase values were normalised to renilla values and expressed as mean fold increase 
from untreated cells.  Measurements were averaged from 6-fold replicates to minimize pipetting 
errors and repeated at least three times to confirm results. Statistical analyses were performed using 
MSExcel software and a one tailed t-test to measure the significance of fold activity. 
 
  
 
4.5  RT – PCR  
Total RNA was prepared from embryonic day 5 (E5) chick neural tube and E17 cerebellum and the 
human–derived cell line SK-N-AS using the RNeasy mini kit (Qiagen). First strand cDNA was produced 
using either Reverse Transcription (Promega) or First- Strand cDNA Synthesis (Invitrogen) kits in 
accordance with manufacturer’s protocols. RT-PCR was performed using chicken FUS primers 
designed to bridge adjacent exons: forward 5’-CCAACGATTACAGCCAGACC-3’ and reverse 5’-
GAAACCTTGATGGGGTTGC-3’ and platinum Taq DNA polymerase (Promega) following 
manufacturer’s protocol. Amplicon size was 994bp when derived from cDNA.  Endogenous FUS 
expression in SK-N-AS cell line was confirmed by RT-PCR from purified total RNA preparations using 
the following primers: (forward) 5’- AGGTGACTGTTTAGTGGGTAGGTC-3’ and (reverse) 5’-
ATAGCCGGACACAGTATCTCA CAC-3’. 
 
4.6   Reporter gene construction for in vivo analysis in chick embryo model. 
Tomato reporter gene sequence was PCR-amplified from pG-TdTomato (a kind gift from Marco 
Marcello, University of Liverpool) using primers forward 5’-
ATAGGAATTCCGTGTACGGTGGGAGGTCTA-3’  and reverse 5’- 
GGCCGTCGACATCATTTTACGTTTCTCGTTC-3’.  These introduced Eco RI and Sal I restriction sites as 
indicated, for directional cloning into the plasmid pIRES EGFP (kind gift from John Gilthorpe King’s 
College London). The pIRES EGFP cassette was removed from the vector using EcoRI and XhoI 
restriction sites and replaced by the Tomato reporter gene, such that the Tomato reporter was 
located downstream of the chick beta actin promoter. 
For the in vivo analysis of FUS promoter in chick embryos, human FUS gene promoter fragments 
ECR PP (582bp) and PP (243bp) were cut out from their pGL3b plasmids using Sacl and Bglll 
restriction enzymes.  These fragments were cloned into the BamHI/XbaI sites of the multicloning site 
of promoter-less vector phrGFP (Stratagene, UK) upstream of the GFP reporter gene. The clones 
were named ECR PP GFP and PP GFP. 
In order to clone the putative regulatory element from FUS intron 1 into a location upstream of 
the FUS promoter sequence in ECR PP GFP and PP GFP a 704bp fragment was PCR-amplified from 
human genomic DNA (Promega) using proofreading Phusion DNA polymerase (NEB, UK) and primers 
5’-GATGAGATCTATGGCCTCAAACGGTAGGTAAGG and 5’-
AGGTGCTAGCGAAAGAAATTTAGGCGGGAAAAACTCTCGGGC introducing NheI and BglII restriction 
sites for directional cloning. The resulting constructs were named INT ECR PP GFP and INT PP GFP, 
respectively. 
 
4.7  Electroporation of chick embryos 
Fertile chicken eggs were incubated at 37.8 °C for about 60-65 hours until they were approximately 
developmental stage 14 HH.  2-3 ml of albumen was removed and a window was cut in the egg. 
Embryos were staged according to Hamburger and Hamilton (1951). In those at stage 11-14 the 
vitelline membrane was removed to aid manipulation of the embryo. The lumen of the neural tube 
was injected with a solution containing 2-5 μg/μl of test DNA reporter plasmid, 1μg/μl of TdTomato 
plasmid (control for successful injection) in PBS and 1mM MgCl2 containing 0.2% fast green to help 
visualization. Injections were undertaken with a micropipette pulled from borosilicate capillaries 
(Warner Instruments). Post-injection, DNA was immediately electroporated into the cells of the 
neural tube; gold plated electrodes of 3mm length (Harvard Apparatus) were placed either side of 
the embryo with an internal gap of 5mm and five 50ms square wave pulses with 100ms gaps were 
delivered [27].  Electroporated embryos were incubated at 37.8?C for at least 48 hours until they 
were approximately HH stage 25 or E5 and then assessed for expression of hrGFP and TdTomato.  
Electroporated embryos were dissected free of membranes and yolk and photographed using 
epifluorescent microscopy.  Red fluorescence was photographed on the same settings (previously 
determined to be appropriate) to determine the consistency of electroporation.  Green fluorescence 
was photographed on consistent settings and where necessary on longer exposures such that faint 
fluorescence could be documented.  The GFP fluorescence was recorded as either present or absent 
without further quantification.   
 
4.8  Immunofluorescence 
Dissected embryos were washed with PBS and fixed using 4% parafomaldehyde (w/v) in 0.12M 
phosphate buffer for 1 h.  The trunks of the embryos were dissected out and placed sequentially in 
6%, 12 % and 18% (w/v) sucrose solution until the tissues sank. Embryonic tissues were then 
mounted in Cryo-M-Bed embedding compound (VWR International Ltd.), frozen in isopentane held 
over liquid nitrogen and 10μm cryostat sections cut [28]. 
 
For immunofluorescence, the following primary antibodies were used: Rabbit anti Fus (1:500,Abcam 
ab23439), Mouse Hb9, (1:5,Developmental Studies Hybridoma Bank, Department of Biology, 
University of Iowa).  Secondary antibodies were goat anti mouse alexa488 1:250 and goat anti rabbit 
alexa488 1:250 (Invitrogen) [28].  Cell nuclei were detected with DAPI.   
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 Figure Legends 
Figure 1 Schematic representation of FUS gene locus organization and reporter gene construct 
design.  (A) Human FUS is located in p11.2 on chromosome 16. A human region upstream of the 
prospective promoter to exon 3 is expanded and aligned with corresponding FUS genomic regions of 
chimp, dog, mouse and rat highlighting evolutionary conservation in coding and non-coding 
sequences of the FUS locus (ECR browser; [29]). Bent arrow indicates transcriptional start (MTSS) 
and ATG indicates the first translated codon. Three regions, non-coding ECR (classical evolutionary 
conserved region), PP (proximal promoter) and INT (intron 1) were cloned. (B) For SK-N-AS and NSC-
34 cell culture experiments regions of interest were cloned into either pGL3-Promoter containing 
minimal SV40 promoter (mP) or pGL3-Basic (without minimal SV40 promoter) vectors using firefly 
luciferase (Luc) as the reporter gene. (C) For in vivo studies in chick embryos, regions of interest 
were cloned into vector phrGFP using GFP as the reporter gene.  
 
Figure 2 Dual luciferase assys of FUS reporter gene constructs in SK-N-AS and NSC-34 cells. (A) FUS 
promoter constructs cloned into promoter-less pGL3b expressed in SK-N-AS cells. All three 
constructs were significantly different when compared with pGL3b (p<0.002 PP and PP-INT, p<0.002 
ECR-PP). ECR-PP and PP-INT had significantly higher transcriptional activity (p<0.04, p<0.03 
respectively) than PP alone.  (B, C) Upstream (ECR) and intronic (INT) FUS putative regulatory 
domains cloned into minimal SV40 promoter-controlled pGL3p and expressed in SK-N-AS cells (B) 
and NSC-34 (C). Both ECR and INT increased luciferase expression compared to the SV40 promoter in 
SK-N-AS cells (p<0.02, p<0.0002) and NSC-34 cells (p,0.02, p<0.004).  Bars represent the fold change 
in firefly luciferase activity normalized against renilla luciferase activity and mean calculated from n 
experiments. Transfection experiments were performed in double triplicates.  
 
Figure 3 FUS is expressed in the neural tube of E5 chick embryos 
Frozen section of E5 chick embryo stained with (A). FUS antisera, (B). DAPI.  FUS is ubiquitously 
expressed in all cells in the section including cells in the developing motor column. Scale bar 100μm 
(C). RT-PCR of E5 neural tube and E17 cerebellum.  The arrow indicates 994bp the expected size of 
the FUS PCR product.   
 
Figure 4 ECR PP enhances expression compared to PP alone 
(A,B) and (C) show embryos that have been electroporated with 1μg/μl dTomato, 2.2 μg/μl ECR PP 
GFP.   (A) dTomato fluorescence indicating successful electroporation.  (B) GFP fluorescence 
indicating the activity of ECR PP in the neural tube.  (C) Bright field showing the location of the four 
successfully electroporated chick embryos.  The arrow indicates the electroporated trunk region of 
one of the embryos. Scale bar 2mm.  (D, E and F) are frozen sections of one of the embryos from (A, 
B and C).  (D) shows the extent of successful electroporation in the neural tube.  It is restricted to the 
left hand side as the DNA within the neural tube is directed to the cathode.  (E) shows that ECR PP 
drives GFP expression in all the electroporated cells including the developing motor neurons. Scale 
bar 100μm  (G, H and I) show embryos that have been electroporated 1μg/μl dTomato, 2.0 μg/μl PP 
GFP.  (G) is TdTomato, (H) PP GFP and (I) bright field.  Scale bar 2mm 
 
Figure 5 INT and INT ECR enhance expression compared to PP alone 
(A, B and C) show embryos that have been electroporated with 1μg/μl dTomato, 3 μg/μl INT PP GFP.   
(A) dTomato fluorescence indicating successful electroporation.  (B) GFP fluorescence indicating the 
activity of ECR PP in the neural tube. Scale bar 1mm  (C) Bright field.  (D, E and F) show embryos that 
have been electroporated with 1μg/μl TdTomato, 3 μg/μl INT ECR PP.   D. dTomato fluorescence.  E. 
GFP fluorescence indicating the activity of INT ECR PP in the neural tube.  F. Bright field.  Scale bar 
500 μm  
 
Supplementary figure 1 Hb9 staining indicates the motor column in E5 neural tube 
Frozen section of E5 neural tube was stained with anti Hb9.  Hb9 is expressed specifically in the 
nuclei of motor neurons.  Scale bar 100μm 
 
Supplementary figure 2 PP drives GFP expression in SKNAS cells 
SKNAS cells were transfected with (A, B) TdTomato, (C, D) ECR PP GFP, (E, F) PP GFP and (G, H) phr 
GFP.  (A, C, E and G) show transfected cells and (B, D, F and H) show phase contrast micrographs of 
SKNAS cells.  PP GFP was successfully transfected SKNAS cells along with TdTomato and ECR PP GFP.  
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